Interference with TGF-β signaling decreases NRP2 expression below levels of untreated cells (Fig. 3a), indicating autocrine regulatory TGF-β signaling in mesenchymal-like HCC cells [37]. The gene discussed is TGFB1; the disease is hepatocellular carcinoma.